Egnyte | A Checklist for Life Sciences Collaboration

Webinar Details

On-Demand

Topics include:

Centralize content across R&D
Secure collaboration across partner networks
Improve operational efficiency

Speakers include:

Adrian Dupre
Sr. Director IT
Icosavax

Abhay Kini
Director of Life Sciences
Egnyte

Duration of webinar:

30 minutes, including live Q&A

Watch The On-Demand Webinar

Clinical-stage biotechs, such as Icosavax, need tools & processes that empower collaborators to work securely and efficiently. This usually means facilitating cloud-based collaboration through business application suites like Microsoft 365 or Google Workspace. For others, it means leveraging cloud solutions to transfer and store clinical data while monitoring audit trails.

Join us as we speak with Adrian Dupre, Senior Director of IT at Icosavax, to discuss how they use Egnyte to share clinical trial data more effectively and collaborate with multiple CROs in their quest to develop VLP-based vaccines that empower better immune response.

About Icosavax:

Icosavax was founded in 2017 with a mission to protect at-risk populations through the discovery, development, and commercialization of vaccines for severe, life-threatening infectious diseases. Icosavax is advancing breakthrough virus-like particle (VLP) technology that enables multivalent, particle-based display of complex viral antigens, which we believe can induce broad, robust, and durable protection against the targeted viruses. Our pipeline includes clinical and preclinical development focused on respiratory syncytial virus (RSV), human metapneumovirus (hMPV), COVID-19 (SARS-CoV-2), and flu.